Ash Stevens Receives 2014 Lilly Global Supplier Award
Ash Stevens receives the 2014 Lilly Global Supplier Award.
Ash Stevens, a provider of global contract pharmaceutical drug substance development and API manufacturing services, received a 2014 Lilly Global Supplier Award.
“We are honored to receive this award and recognition from Eli Lilly and Company. Ash Stevens has a rich history that exceeds 50 years conducting innovative chemical research to develop and manufacture a wide variety of active pharmaceutical ingredients," said Dr. Stephen Munk, president and CEO.
To date, Ash Stevens has received twelve FDA manufacturing approvals for new APIs, including four fast-track manufacturing approvals for the active ingredients in the oncology drugs Velcade, Vidaza, Clolar, and Iclusig.
Source: Ash Stevens
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
